Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction
about
Cardiopulmonary resuscitation with assisted extracorporeal life support during cardiac arrest caused by drug-eluting stent thrombosis: a case report.Perioperative blood management strategies for patients undergoing total knee replacement: Where do we stand now?Bleeding and first-year mortality following hip fracture surgery and preoperative use of low-dose acetylsalicylic acid: an observational cohort study.Alternative procedures for reducing allogeneic blood transfusion in elective orthopedic surgery.Ureteroscopy in patients with coagulopathies is associated with lower stone-free rate and increased risk of clinically significant hematuria.Peri-operative management of anti-platelet agents and anti-thrombotic agents in geriatric patients undergoing semi-urgent hip fracture surgeryEffect of early surgery in high surgical risk geriatric patients with femoral neck fracture and taking antiplatelet agentsAllosterism-based simultaneous, dual anticoagulant and antiplatelet action: allosteric inhibitor targeting the glycoprotein Ibα-binding and heparin-binding site of thrombin.Is discontinuation of clopidogrel necessary for intracapsular hip fracture surgery? Analysis of 102 hemiarthroplasties.Expanding the recognition and assessment of bleeding events associated with antiplatelet therapy in primary care.Clinical Pearls in perioperative medicine.Safety of clopidogrel in hip fracture surgery.Antiplatelet drugs and the perioperative period: What every urologist needs to knowSafety and tolerability of antiplatelet therapies for the secondary prevention of atherothrombotic disease.Dental extraction can be performed safely in patients on aspirin therapy: a timely reminderPerioperative management of antiplatelet-drugs in cardiac surgery.Prevention of the renarrowing of coronary arteries using drug-eluting stents in the perioperative period: an update.The management of antiplatelet therapy in patients with coronary stents undergoing noncardiac surgery.Management of patients with recently implanted coronary stents on dual antiplatelet therapy who need to undergo major surgery.The management of patients on dual antiplatelet therapy undergoing orthopedic surgery.Antiplatelet agents for the treatment and prevention of atherothrombosis.A retrospective study to assess the morbidity associated with transurethral prostatectomy in patients on antiplatelet or anticoagulant drugs.Antiplatelet therapy in ENT surgery: a review.Clopidogrel dilemma for orthopaedic surgeons.Perioperative antiplatelet management in patients with coronary artery stenting.Perioperative management of antiplatelet therapy in patients with drug-eluting stents.Bridge with intravenous antiplatelet therapy during temporary withdrawal of oral agents for surgical procedures: a systematic review.Algorithm for anticoagulation management in geriatric hip fracture patients--Surgeons save Blood.Management of peri-operative anti-thrombotic therapy.Treatment of ruptured blood blister aneurysms using primary flow-diverter stenting with considerations for adjunctive coiling: A single-centre experience and literature review.Clinically relevant exaggerated pharmacodynamic response to dual antiplatelet therapy detected by Thromboelastogram(®) Platelet Mapping™.Prospective multicentre cohort study on 9154 surgical procedures to assess the risk of postoperative bleeding - a DESSI study.The efficacy of laparoscopic cholecystectomy without discontinuation in patients on antithrombotic therapyShould aspirin be stopped before carpal tunnel surgery? A prospective study.Cangrelor in patients undergoing cardiac surgery: the BRIDGE study.Thrombin based gelatin matrix and fibrin sealant mediated clot formation in the presence of clopidogrel.Discontinuation of anticoagulant or antiplatelet therapy for transrectal ultrasound-guided prostate biopsies: a single-center experience.Right middle cerebral artery aneurysm posted for clipping on dual anti-platelet therapy.Perioperative cardioprotection.Non-ST Elevation Myocardial Infarction and Coronary Artery Stenting in Pregnancy in a Woman with Resistant Familial Hyperlipidaemia.
P2860
Q33700875-C7059C3F-1BE5-4BFF-915E-2F08C135EF52Q33818396-53FA30B5-0325-447A-B8B0-2E2F61654BE8Q34068661-58A6997E-2E50-44D0-9F1C-33E72FE531B2Q34079843-64F1A1B4-B35A-40E0-9E8F-CED80EC9910BQ34255256-17C161E0-02FF-4923-94B5-3A90CAED6419Q34283927-9788A8BF-5270-4F19-A3B0-BDABCC4F6B30Q36391386-BDF777F7-D0ED-4A7A-984A-836B91F0009CQ36788507-01CDB0CD-D246-43E0-BC45-945F38A742D9Q37115439-5C286E34-44D5-49DC-B349-61CA6333CFC6Q37148386-D5530DC4-4707-412F-9504-D055DEBCD4D7Q37207968-04CC42AE-4273-4652-8B0E-86FDA7B6E5C7Q37335238-DDE609C2-185F-4782-9D85-43C01EFB737CQ37427253-8F77B4FE-65B1-4472-B1C4-2F588616C8C3Q37532491-37A396B4-5D37-4F90-AB9A-EA3E459DC978Q37731105-25DFD769-69BA-48FE-8ABE-22D72755FDB8Q37740975-68278068-415B-4D57-8E73-B720EC3D5975Q37801291-B16146F5-B796-4CFB-B8C1-A22D46C02913Q37808050-065D0376-A157-42A8-80E4-64B13B5AB252Q37912273-5596011C-1C6C-4676-8FA8-C97A7DECD476Q37925501-CEC24259-10B3-48E6-9D8C-5B6DDA7A0A9DQ37948506-BBC66326-5E38-4801-9BAA-8F0D4D4FFEAEQ37956372-B91D4A66-BE91-4984-8946-48E17CE9E79DQ37969848-DD8E9CD5-FB84-4936-BAAE-4003DBBC54C6Q37980467-26DE2D66-ABD7-43A0-B39E-F5DF8F49E2B6Q38012080-305448E9-344B-4B14-A470-9BF581CCB5BFQ38084549-7322179F-E8C4-493B-B327-C7CE6D180C00Q38178106-5A0B984D-50E1-4770-BD25-8D2055AD557EQ38195191-465F6CB1-0651-49D0-B0C4-EC13F33C8F8AQ38273789-E558B41E-BB53-4D30-BF26-02A9D4BF160EQ38652268-C8087E3E-6D1C-43A1-9D6E-CF7C76999EC7Q38867482-DEDD145B-780D-4465-B2D7-0AA2B744F68EQ39099656-EABCAB49-1D10-46CE-B71F-C0BA09305556Q39176883-F98BAEB0-3E46-475A-BCD2-7DA3D111D5CFQ39218594-D9B9A1F4-87C9-47EF-AFDD-6E11808D877FQ39376345-1A96712E-53F2-489B-9E9E-9645563AD898Q40161287-4C78B7B1-041B-4DC5-9294-63679618E9D7Q40288939-B9D1C29E-620C-43C2-9C1E-8E583DD5B4CCQ40765798-69D016E3-0862-4C2C-B2B0-4C3C4DEB15D6Q41498749-E2AFFA28-5817-4A0A-B233-CA81031A6B52Q41579523-F7B3DDE7-12A9-49D7-9E43-E54EE010F42B
P2860
Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Perioperative antiplatelet the ...... risk of myocardial infarction
@ast
Perioperative antiplatelet the ...... risk of myocardial infarction
@en
Perioperative antiplatelet the ...... risk of myocardial infarction
@nl
type
label
Perioperative antiplatelet the ...... risk of myocardial infarction
@ast
Perioperative antiplatelet the ...... risk of myocardial infarction
@en
Perioperative antiplatelet the ...... risk of myocardial infarction
@nl
prefLabel
Perioperative antiplatelet the ...... risk of myocardial infarction
@ast
Perioperative antiplatelet the ...... risk of myocardial infarction
@en
Perioperative antiplatelet the ...... risk of myocardial infarction
@nl
P2093
P356
P1476
Perioperative antiplatelet the ...... risk of myocardial infarction
@en
P2093
A Delabays
P-G Chassot
P304
P356
10.1093/BJA/AEM209
P407
P577
2007-09-01T00:00:00Z